Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Biosystems

• Publication date

  2012-04-03

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1039/c2mb05503aPMID 22446875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery of dual target inhibitors against cyclooxygenases and leukotriene A4 hydrolyase.

  2011cited by this paper
• Lipidomic Analysis of Dynamic Eicosanoid Responses during the Induction and Resolution of Lyme Arthritis*

  2009cited by this paper
• Arylpyrrolizines as inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1) or as dual inhibitors of mPGES-1 and 5-lipoxygenase (5-LOX).

  2009cited by this paper
• Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis.

  2009cited by this paper
• Synergistic drug combinations improve therapeutic selectivity

  2009cited by this paper
• MF63 [2-(6-Chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a Selective Microsomal Prostaglandin E Synthase-1 Inhibitor, Relieves Pyresis and Pain in Preclinical Models of Inflammation

  2008cited by this paper
• Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.

  2008cited by this paper
• Microsomal prostaglandin E2 synthase-1 (mPGES-1): a novel anti-inflammatory therapeutic target.

  2008cited by this paper
• Finding multiple target optimal intervention in disease-related molecular network

  2008cited by this paper
• Licofelone Suppresses Prostaglandin E2 Formation by Interference with the Inducible Microsomal Prostaglandin E2 Synthase-1

  2008cited by this paper
• Development and validation of a high-performance liquid chromatography-electrospray mass spectrometry method for the simultaneous determination of 23 eicosanoids.

  2008cited by this paper
• Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors.

  2008cited by this paper
• Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.

  2008cited by this paper
• New approaches to the modulation of the cyclooxygenase-2 and 5-lipoxygenase pathways.

  2007cited by this paper
• Dynamic Simulations on the Arachidonic Acid Metabolic Network

  2007cited by this paper
• Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers.

  2007cited by this paper
• A robustness-based approach to systems-oriented drug design

  2007cited by this paper
• Inflammation and immune regulation by 12/15-lipoxygenases.

  2006cited by this paper
• Monitoring eicosanoid biosynthesis via lipoxygenase and cyclooxygenase pathways in human whole blood by single HPLC run.

  2006cited by this paper
• Eicosanoid Transcellular Biosynthesis: From Cell-Cell Interactions to in Vivo Tissue Responses

  2006cited by this paper
• Lipoxins and new lipid mediators in the resolution of inflammation.

  2006cited by this paper
• Pharmacological intervention with 5-lipoxygenase: new insights and novel compounds

  2005cited by this paper
• Resolution of inflammation: the beginning programs the end

  2005cited by this paper
• Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis.

  2005cited by this paper
• FDA to review risks of antidepressants in adults

  2004cited by this paper
• The efficiency of multi-target drugs: the network approach might help drug design.

  2004cited by this paper
• Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.

  2004cited by this paper
• Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis.

  2004cited by this paper
• Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis

  2003cited by this paper
• Cyclooxygenase‐2 and 5‐lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy

  2003cited by this paper
• Tenidap, a novel anti-inflammatory agent, is an opener of the inwardly rectifying K+ channel hKir2.3.

  2002cited by this paper
• Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution.

  2002cited by this paper
• New trends in dual 5-LOX/COX inhibition.

  2002cited by this paper
• Points of control in inflammation

  2002cited by this paper
• Risk of cardiovascular events associated with selective COX-2 inhibitors.

  2001cited by this paper
• Lipid mediator class switching during acute inflammation: signals in resolution

  2001cited by this paper
• Prostaglandins and leukotrienes: advances in eicosanoid biology.

  2001cited by this paper
• Aspirin and asthma.

  2000cited by this paper
• Structure−Activity Relationship Studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a Potent Inhibitor of Leukotriene A4 (LTA4) Hydrolase

  2000cited by this paper
• Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.

  2000cited by this paper
• Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis.

  1999cited by this paper
• Allergic lung responses are increased in prostaglandin H synthase-deficient mice.

  1999cited by this paper
• The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice.

  1996cited by this paper
• The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: structure-activity relationship and mechanism of action.

  1996cited by this paper
• Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and-2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production

  1996cited by this paper
• Lipoxygenase product formation and cell adhesion during neutrophil-glomerular endothelial cell interaction.

  1995cited by this paper
• The Role of Leukotrienes in Inflammation

  1994cited by this paper
• Altered inflammatory responses in leukotriene-deficient mice.

  1994cited by this paper
• Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs.

  1993cited by this paper
• Mechanism-based inactivation of leukotriene A4 hydrolase/aminopeptidase by leukotriene A4. Mass spectrometric and kinetic characterization.

  1992cited by this paper
• 5-lipoxygenase inhibitory activity of zileuton.

  1990cited by this paper
• "Suicide" inactivation of thromboxane A2 synthase. Characteristics of mechanism-based inactivation with isolated enzyme and intact platelets.

  1990cited by this paper
• Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine.

  1989cited by this paper
• 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.

  1988cited by this paper
• The role of arachidonic acid oxygenation products in pain and inflammation.

  1984cited by this paper
• Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

  1979cited by this paper
• The Primary Working Group

  1963cited by this paper

• Metabolomic responses to shipping noise in early life stages of blue mussels, Mytilus edulis.

  2025cites this paper
• Uses of Molecular Docking Simulations in Elucidating Synergistic, Additive, and/or Multi-Target (SAM) Effects of Herbal Medicines

  2024influential citation
• Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors.

  2024cites this paper
• Synthesis and In Vitro Biological Evaluation of p-Carborane-Based Di-tert-butylphenol Analogs

  2023cites this paper
• Mathematical Modeling of Eicosanoid Metabolism in Macrophage Cells: Cybernetic Framework Combined with Novel Information-Theoretic Approaches

  2023cites this paper
• Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201

  2022cites this paper
• Polypharmacology: The Science of Multi-targeting Molecules.

  2022cites this paper
• Metabolomics Signature and Potential Application of Serum Polyunsaturated Fatty Acids Metabolism in Patients With Vitiligo

  2022cites this paper
• Synthesis and structure–activity relationships for some novel diflapolin derivatives with benzimidazole subunit

  2022cites this paper
• Arachidonic Acid Cascade and Eicosanoid Production Are Elevated While LTC4 Synthase Modulates the Lipidomics Profile in the Brain of the HIVgp120-Transgenic Mouse Model of NeuroHIV

  2022cites this paper
• Natural chalcones elicit formation of specialized pro-resolving mediators and related 15-lipoxygenase products in human macrophages.

  2021cites this paper
• Serum Metabolomics study of Patients with Allergic Rhinitis.

  2020cites this paper
• Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP).

  2020cites this paper
• Screening drug target combinations in disease-related molecular networks

  2019cites this paper
• Impact of food polyphenols on oxylipin biosynthesis in human neutrophils.

  2019cites this paper
• Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome

  2019cites this paper
• Frontline Science: Reprogramming COX‐2, 5‐LOX, and CYP4A‐mediated arachidonic acid metabolism in macrophages by salidroside alleviates gouty arthritis

  2018cites this paper
• Identification of multi-target inhibitors of leukotriene and prostaglandin E2 biosynthesis by structural tuning of the FLAP inhibitor BRP-7.

  2018cites this paper
• Inhibition of COX‐2/mPGES‐1 and 5‐LOX in macrophages by leonurine ameliorates monosodium urate crystal‐induced inflammation

  2018cites this paper
• Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds.

  2018cites this paper
• Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation.

  2018cites this paper
• Two‐pronged approach to anti‐inflammatory therapy through the modulation of the arachidonic acid cascade

  2018cites this paper
• [Pathogenic role of leukotriene B4 in pulmonary microvascular endothelial cell hyper- permeability induced by one lung ventilation in rabbits].

  2017cites this paper
• Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase

  2017cites this paper
• [Relationship between cytoplasmic phospholipase A2 and nuclear factor κB in one lung ventilation-induced lung injury in rabbits].

  2017cites this paper
• Discovery of Novel 15-Lipoxygenase Activators To Shift the Human Arachidonic Acid Metabolic Network toward Inflammation Resolution.

  2016cites this paper
• Is metabolism goal-directed? Investigating the validity of modeling biological systems with cybernetic control via omic data

  2016cites this paper
• Dimethyl ester of bilirubin exhibits anti-inflammatory activity through inhibition of secretory phospholipase A2, lipoxygenase and cyclooxygenase.

  2016cites this paper
• Small molecules with anti-inflammatory properties in clinical development.

  2016cites this paper
• Transcriptomic response to water accommodated fraction of crude oil exposure in the gill of Japanese flounder, Paralichthys olivaceus.

  2016cites this paper
• Potential Antifungal Targets against a Candida Biofilm Based on an Enzyme in the Arachidonic Acid Cascade—A Review

  2016cites this paper
• Serum Dyslipidemia Is Induced by Internal Exposure to Strontium-90 in Mice, Lipidomic Profiling Using a Data-Independent Liquid Chromatography-Mass Spectrometry Approach.

  2015cites this paper
• In vivo solid-phase microextraction liquid chromatography-tandem mass spectrometry for monitoring blood eicosanoids time profile after lipopolysaccharide-induced inflammation in Sprague-Dawley rats.

  2015cites this paper
• Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation.

  2015cites this paper
• Systems biology brings new dimensions for structure-based drug design.

  2014cites this paper
• Liquid chromatography-tandem mass spectrometry analysis of eicosanoids and related compounds in cell models.

  2014cites this paper
• Multi-dimensional target profiling of N,4-diaryl-1,3-thiazole-2-amines as potent inhibitors of eicosanoid metabolism.

  2014cites this paper
• Benzo[d]isothiazole 1,1-dioxide derivatives as dual functional inhibitors of 5-lipoxygenase and microsomal prostaglandin E(2) synthase-1.

  2014cites this paper
• Inhibitors of the arachidonic acid cascade: interfering with multiple pathways.

  2014cites this paper
• Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer’s disease in CRND8 mice

  2013cites this paper
• Understanding traditional Chinese medicine anti-inflammatory herbal formulae by simulating their regulatory functions in the human arachidonic acid metabolic network.

  2013cites this paper
• 5-Lipoxygenase inhibitors: a review of recent patents (2010 – 2012)

  2013cites this paper
• A Mouse Model of Early-Onset Renal Failure Due to a Xanthine Dehydrogenase Nonsense Mutation

  2012cites this paper